NCT04095637 RCT: Mako Medial Unicondylar Knee Arthroplasty vs Oxford Unicondylar Knee Arthroplasty
| NCT ID | NCT04095637 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University College, London |
| Condition | Unicompartmental Knee Replacement |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2017-11-24 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2017-11-24 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim of this prospective, randomised, single-blinded, controlled trial is to compare clinical outcomes and accuracy of implant positioning in Mako robotic UKA versus jig-based Oxford UKA with navigation control. Patients receiving the Mako robotic UKA (Stryker Ltd) will form the investigation group and those undergoing the jig-based Oxford UKA (Zimmer-Biomet Ltd) with navigation control will form the control group. The primary objective in this study is to compare accuracy of component positioning as assessed by postoperative low radiation dose CT scan between conventional Jig-based Oxford UKA with navigation control and Mako robotic UKA.
Eligibility Criteria
Inclusion Criteria: * • Patient has medial unicompartmental knee osteoarthritis requiring primary UKA * Patient and Surgeon are in agreement that UKA is the most appropriate treatment * Patient is fit for surgical intervention following review by surgeon and anaesthetist * Patient is between 40-80 years of age at time of surgery * Gender: male and female * Patient must be capable of giving informed consent and agree to comply with the postoperative review program * Patient must be a permanent resident in an area accessible to the study site * Patient must have sufficient postoperative mobility to attend follow-up clinics and allow for radiographs to be taken Exclusion Criteria: * • Patient is not suitable for primary UKA e.g. multi-compartmental knee osteoarthritis, anterior cruciate ligament rupture * Patient is not medically fit for surgical intervention * Patient requires revision surgery following previously failed correctional osteotomy or ipsilateral UKA * Patient is immobile or has another neurological condition affecting musculoskeletal function * Patient is less than 40 years of age or greater than 80 years of age * Patient is already enrolled on another concurrent clinical trial * Patient is unable or unwilling to sign the informed consent form specific to this study * Patient is unable to attend the follow-up programme * Patient is non-resident in local area or expected to leave the catchment area postoperatively
Contact & Investigator
Fares S Haddad
STUDY CHAIR
UCL Hospitals NHS Foundation Trust
Frequently Asked Questions
Who can join the NCT04095637 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Unicompartmental Knee Replacement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04095637 currently recruiting?
Yes, NCT04095637 is actively recruiting participants. Contact the research team at jenni.tahmassebi1@nhs.net for enrollment information.
Where is the NCT04095637 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT04095637 clinical trial?
NCT04095637 is sponsored by University College, London. The principal investigator is Fares S Haddad at UCL Hospitals NHS Foundation Trust. The trial plans to enroll 140 participants.